Verona Pharma plc VRNA

$ 41.98 1.83%

Quarterly report 2024-Q3
added 11-04-2024

Verona Pharma plc Income Statement 2011-2024 | VRNA

Annual Income Statement Verona Pharma plc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	11 B	10.8 B	3.18 B	261 M	72.5 M	77.6 M	141 M	-	-	-	-	-	-
Shares	634 M	529 M	473 M	33 M	13 M	13 M	11 M	-	-	-	-	-	-
Historical Prices	17.4	20.4	6.72	7	5.75	9.65	11.9	-	-	-	-	-	-
Net Income	-54.4 M	-68.7 M	-55.6 M	-65.1 M	-	-	-	-6.19 M	-11 M	-4.29 M	-4.16 M	-4.07 M	-2.67 M
Revenue	-	458 K	40 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	346 K	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	112 K	40 M	-	-	-	-	-	-	-	-	-	-
Operating Income	-67.6 M	-75.8 M	-73.3 M	-74.3 M	-52.4 M	-	-	-	-	-	-	-	-
Interest Expense	2.06 M	521 K	340 K	35 K	-	-	-	-	-	-	-	-	-
EBITDA	-66.9 M	-75.1 M	-72.7 M	-65 M	398 K	8 K	7 K	-8.5 M	-13.2 M	-5.82 M	-4.58 M	-4.13 M	-2.82 M
Operating Expenses	67.6 M	75.9 M	113 M	74.3 M	53.4 M	32.5 M	-40.3 M	-	-	-	-	-	-
General and Administrative Expenses	50.4 M	26.6 M	33.9 M	29.8 M	4.94 M	3.39 M	-8.17 M	1.62 M	1.36 M	1.8 M	1.91 M	1.47 M	1.12 M

All numbers in USD currency

Quarterly Income Statement Verona Pharma plc

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	652 M	648 M	644 M	638 M	634 M	621 M	606 M	544 M	485 M	482 M	480 M	475 M	471 M	469 M	463 M	345 M	106 M	105 M	105 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-43 M	-70.8 M	-	-14.7 M	-8.81 M	-16.7 M	-	-15.6 M	-17.8 M	-24.8 M	-	11.1 M	-22.1 M	-21.3 M	-	-18.9 M	-9.04 M	-12.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	5.62 M	-	-	-	-	-	-	-	-	-	-	40 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	40 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-40.7 M	-68.4 M	-	-16.3 M	-9.96 M	-22.2 M	-	-15.1 M	-20.5 M	-25.1 M	-	6.56 M	-28.5 M	-22.9 M	-	-21.1 M	-11 M	-14.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	9.88 M	1.76 M	-	401 K	740 K	293 K	-	116 K	91 K	84 K	-	86 K	85 K	84 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-22 M	-	-14.6 M	-20.2 M	-24.9 M	-	7.02 M	-28.2 M	-22.7 M	-	-20.6 M	-10.7 M	-14.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	46.3 M	68.4 M	-	16.3 M	9.96 M	22.2 M	-	15.1 M	20.5 M	25.1 M	-	33.4 M	28.5 M	22.9 M	-	21.1 M	11 M	14.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	35.2 M	49 M	-	13.4 M	12.4 M	9.59 M	-	5.29 M	5.53 M	7.44 M	-	10.9 M	7.98 M	9.28 M	-	8.28 M	3.17 M	6.86 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency